Takeda, Lilly Jury Awards $9 Billion Over Actos Cancer Risks

April 9th, 2014

Via: Bloomberg:

Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.

Leave a Reply

You must be logged in to post a comment.